Your search for Emerging Technologies/Treatments returned the following most recent results.

Regulatory Science Symposium: Emerging Technologies/Treatments Session 1 - Regulatory Considerations (2017)

In this series, we will discuss regulatory considerations for conducting clinical trials in the era of emerging technologies and treatments.

regulatory science

Regulatory Science Symposium: Emerging Technologies/Treatments Session 5 - Immunotherapy Trials (2017)

In this series, we will discuss regulatory considerations for conducting clinical trials in the era of emerging technologies and treatments.

regulatory science

Regulatory Science Symposium: Emerging Technologies/Treatments Session 2: Gene Therapy Trials and Tribulations (2017)

In this series, we will discuss regulatory considerations for conducting clinical trials in the era of emerging technologies and treatments.

regulatory science

Regulatory Science Symposium: Emerging Technologies/Treatments Session 3: Clinical Trials for Stem Cell Therapies (2017)

In this series, we will discuss regulatory considerations for conducting clinical trials in the era of emerging technologies and treatments.

regulatory science

Regulatory Science Symposium: Emerging Technologies/Treatments Session 4: CT Enabling Technologies – Decentralized Clinical Trials (2017)

In this series, we will discuss regulatory considerations for conducting clinical trials in the era of emerging technologies and treatments.

regulatory science

Regulatory Science Symposium: Emerging Technologies/Treatments Session 6: Cutting Edge Technologies and Humanitarian Devices (2017)

In this series, we will discuss regulatory considerations for conducting clinical trials in the era of emerging technologies and treatments.

regulatory science

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.